CN Patent

CN119876138A — 调节性多核苷酸

Assigned to Voyager Therapeutics Inc · Expires 2025-04-25 · 1y expired

What this patent protects

本发明涉及调节性多核苷酸，具体而言，本发明涉及调节性多核苷酸的组合物和制备、生产的方法以及治疗用途。

USPTO Abstract

本发明涉及调节性多核苷酸，具体而言，本发明涉及调节性多核苷酸的组合物和制备、生产的方法以及治疗用途。

Drugs covered by this patent

Qalsody (TOFERSEN) · Biogen Ma

Patent Metadata

Patent number: CN119876138A
Jurisdiction: CN
Classification: —
Expires: 2025-04-25
Drug substance claim: No
Drug product claim: No
Assignee: Voyager Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.